|
Volumn 11, Issue 7, 2002, Pages 981-989
|
Advances in pathogenic concepts and therapeutic agents in Rasmussen's encephalitis
a a a |
Author keywords
Antibodies; Antiviral treatment; Autoimmune disease; Cytotoxic T lymphocytes; Epilepsy; GluR3; Immunomodulation; Immunosuppression; Rasmussen's encephalitis; Viruses
|
Indexed keywords
ALPHA INTERFERON;
ANTICONVULSIVE AGENT;
ANTIVIRUS AGENT;
AUTOANTIBODY;
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
GANCICLOVIR;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENT;
METHYLPREDNISOLONE;
ZIDOVUDINE;
AUTOIMMUNITY;
BRAIN DISEASE;
CENTRAL NERVOUS SYSTEM;
CONTROLLED STUDY;
CYTOMEGALOVIRUS;
CYTOTOXIC T LYMPHOCYTE;
ENCEPHALITIS;
EPSTEIN BARR VIRUS;
HEMISPHERE;
HERPES SIMPLEX VIRUS;
HERPES VIRUS;
HUMAN;
IMMUNOADSORPTION;
IMMUNOMODULATION;
IMMUNOPATHOGENESIS;
IMMUNOSUPPRESSIVE TREATMENT;
PATHOGENESIS;
PLASMAPHERESIS;
RASMUSSEN SYNDROME;
REVIEW;
SYMPTOM;
TREATMENT OUTCOME;
CHILD;
DRUG EFFECT;
IMMUNOLOGY;
IMMUNOTHERAPY;
METABOLISM;
NEUROLOGIC DISEASE;
PATHOLOGY;
ANTICONVULSANTS;
AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM;
CHILD;
ENCEPHALITIS;
HUMAN;
IMMUNOTHERAPY;
SUPPORT, NON-U.S. GOV'T;
T-LYMPHOCYTES, CYTOTOXIC;
HUMANS;
|
EID: 0035986913
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.11.7.981 Document Type: Review |
Times cited : (29)
|
References (67)
|